Information for "Analysis about the effectiveness and basic safety of fibrinolytic treatments within patients along with serious STsegment top myocardial infarction during the COVID19 epidemic"
From EECH Central
Basic information
Display title | Analysis about the effectiveness and basic safety of fibrinolytic treatments within patients along with serious STsegment top myocardial infarction during the COVID19 epidemic |
Default sort key | Analysis about the effectiveness and basic safety of fibrinolytic treatments within patients along with serious STsegment top myocardial infarction during the COVID19 epidemic |
Page length (in bytes) | 3,322 |
Page ID | 1427670 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Sonrub0 (Talk | contribs) |
Date of page creation | 14:59, 1 May 2024 |
Latest editor | Sonrub0 (Talk | contribs) |
Date of latest edit | 14:59, 1 May 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |